{"slideshow_credits": null, "snippet": "J. Michael Pearson, the pharmaceutical company\u2019s chief executive, said in a conference call with investors that the company was strong, despite recent issues.", "abstract": "Valeant Pharmaceuticals International chief executive J Michael Pearson attempts to reassure investors in conference call that steep drop in company's stock price is not indication that its future is no longer bright; attributes stock performance to criticisms it has received over large price increase on its drugs and relationship with specialty pharmacy.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK"}, "web_url": "http://www.nytimes.com/2015/11/11/business/valeant-chief-expresses-optimism-about-its-future.html", "lead_paragraph": "J. Michael Pearson, the pharmaceutical company\u2019s chief executive, said in a conference call with investors that the company was strong, despite recent issues.", "headline": {"main": "Valeant Chief Says Issues Stem From Fast Growth", "print_headline": "Valeant Chief Says Issues Stem From Fast Growth "}, "_id": "5642338b38f0d842ce0a8757", "word_count": "1060", "multimedia": [{"height": 126, "url": "images/2015/11/11/business/11valeant-web2/11valeant-web2-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/11/11/business/11valeant-web2/11valeant-web2-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 393, "url": "images/2015/11/11/business/11valeant-web2/11valeant-web2-articleLarge.jpg", "legacy": {"xlarge": "images/2015/11/11/business/11valeant-web2/11valeant-web2-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "393"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/11/11/business/11valeant-web2/11valeant-web2-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/11/11/business/11valeant-web2/11valeant-web2-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-11-11T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "Y", "rank": "1"}, {"name": "persons", "value": "Pearson, John Michael (1959- )", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "3"}, {"name": "subject", "value": "Company Reports", "is_major": "N", "rank": "4"}, {"name": "organizations", "value": "Philidor Rx Services LLC", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}